W Zhu, N Lian, J Wang, F Zhao,
B Liu, J Sheng… - Chinese Medicine, 2024 - Springer
Abstract Background Liguzinediol (Lig) has emerged as a promising candidate for mitigating
Doxorubicin (DOX)-induced cardiotoxicity, a significant limitation in the clinical application of …